Search
for
Sort by
Research 121–150 of 738
- Hyperandrogenism in Adolescent Girls
- Adrenal 21-hydroxylase gene mutations in Slovenian hyperandrogenic women: evaluation of corticotrophin stimulation and HLA polymorphisms in screening for carrier status
- EMQN best practice guidelines for molecular genetic testing and reporting of 21-hydroxylase deficiency
- Society for Endocrinology Clinical Practice Guideline for the Evaluation of Androgen Excess in Women
- Expression and roles of steroidogenic acute regulatory (StAR) protein in ‘non-classical’, extra-adrenal and extra-gonadal cells and tissues
- The investigation and management of severe hyperandrogenism pre- and postmenopause: Non-tumor disease is strongly associated with metabolic syndrome and typically responds to insulin-sensitization with metformin
- Clinical relevance of testosterone and dihydrotestosterone metabolism in women
- An Adult With Hair Loss! a Rare Case of Non-Classical 3β Hydroxysteroid Dehydrogenase (3β HSD) Deficiency
- Polycystic Ovary Syndrome: Update on Diagnosis and Treatment
- PCOS and Obesity: Contraception Challenges
- Adverse effects of 5α-reductase inhibitors: What do we know, don’t know, and need to know?
- Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline
- PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN WOMEN WITH POLYCYSTIC OVARY SYNDROME AND ITS CORRELATION WITH METABOLIC SYNDROME
- A Very Rare Reason for Hyperandrogenism: Adrenal Tumor Case
- Endocrine control of benign prostatic hyperplasia
- Prevalence of CYP21 mutations and IRS1 variant among women with polycystic ovary syndrome and adrenal androgen excess
- Polycystic ovary syndrome: a dermatologic approach
- Clinical Impact of Molecular Diagnostics in Endocrinology
- The Impact of the 5α-Reductase Inhibitors (5α-RIs) on Male Sexual Function and Psychological Well-Being
- Diagnosis and treatments of hirsutism: where are we?
- Managing polycystic ovary syndrome in primary care
- Endocrinopathies and Other Disorders Inducing a Polycystic Ovary Syndrome Phenotype
- Autoimmune Polyglandular Syndrome Type 1 in Russian Patients: Clinical Variants and Autoimmune Regulator Mutations
- Hyperandrogenism in a set of triplets with modification of clinical course by hyperthyroidism
- Skin manifestations of hyperandrogenism: an update
- Treatment of Nonclassic 11-Hydroxylase Deficiency with Ashwagandha Root
- A recently characterized, underdiagnosed cause of female androgenetic alopecia and polycystic ovarian syndrome: non-classical 21 hydroxylase deficiency
- MON-369 Treatment of Nonclassic 11-Hydroxylase Deficiency with "Hair, Skin, and Nails," an Over-the-Counter, Insulin Sensitizing Vitamin/Mineral Supplement
- The role of antimullerian hormone in the hormonal workup of women with persistent acne
- Pharmacological Options for Treatment of Hyperandrogenic Disorders